ERRα, an orphan nuclear receptor, acts as a vital regulator of various events in solid tumors including breast cancer, prostate adenocarcinoma, cervical cancer, and hepatocellular carcinoma, and its expression and activity are largely correlated with tumor aggression and pathological stage [25]. Here, ESRRB is linked to breast carcinoma.